During the past decade, Brighton Gen Hosp conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Brighton Gen Hosp" #1 sponsor was "Abbott" with 2 trials, followed by "Artu Biologicals" with 1 trials sponsored, "Brighton & Sussex Medical School" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "LEO Pharma" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Brighton Gen Hosp" #1 collaborator was "Action Medical Research" with 1 trials as a collaborator, "Brighton and Sussex University Hospitals NHS Trust" with 1 trials as a collaborator, "Guy's and St Thomas' NHS Foundation Trust" with 1 trials as a collaborator, "Trimeris" with 1 trials as a collaborator and "UK Dermatology Clinical Trials Network" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Brighton Gen Hosp" are "HIV Infections" (3 trials), "Actinic Keratosis (AK)" (1 trials), "Allergic Rhinoconjunctivitis" (1 trials), "Cellulitis/Erysipelas of the Leg" (1 trials) and "Food Allergy" (1 trials). Many other conditions were trialed in "Brighton Gen Hosp" in a lesser frequency.

Most popular intervention types in "Brighton Gen Hosp" are "Drug" (6 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lopinavir/Ritonavir" (2 trials), "Enfuvirtide" (1 trials), "Imiquimod Cream, 5%" (1 trials), "Ingenol Mebutate Gel, 0.015%" (1 trials) and "Lamivudine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Brighton Gen Hosp" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Brighton Gen Hosp". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Brighton Gen Hosp, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Brighton Gen Hosp, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".